3D Systems Corporation (DDD) Stock Price & How to Invest

3D Systems Corporation is one of the original additive manufacturing companies, offering a broad portfolio of 3D printers, print materials, software, and on-demand manufacturing services. It reports in two segments. Healthcare Solutions covers dental, medical devices, and regenerative technologies like bioprinting, and in Q1 2026 grew about 21% year over year (roughly $50 million) on strength in Dental and Med Tech, each up over 20%. Industrial Solutions serves aerospace, defense, and general manufacturing and grew more modestly (roughly $45 million). Total Q1 2026 revenue was about $95.5 million, up ~1% reported but ~11% excluding divestitures, and healthcare has grown to a scale that now rivals the industrial business.

The mid-2026 story is a turnaround in progress. After years of losses, 3D Systems has restructured aggressively, cut costs, divested non-core assets, and strengthened its balance sheet (retiring debt while managing convertible notes). Non-GAAP gross margin improved to about 36% in Q1 2026 from roughly 30% a year earlier on a richer product mix, and the GAAP loss per share narrowed to about $(0.03). Adjusted EBITDA turned slightly positive. Notable wins include the NextDent 300 jetted denture printer and adoption by the Cadillac Formula 1 team. Even so, the company remains small (a market cap in the hundreds of millions, with the stock trading around the low single digits) and is not yet consistently GAAP-profitable, so the investment case rests on execution rather than proven earnings power.

The central risk is that 3D Systems is a small, not-yet-consistently-profitable turnaround, so the thesis depends on execution that has not been fully proven. Additive manufacturing demand, especially in industrial markets, is cyclical and can soften with capital-spending pullbacks, while healthcare growth must keep compensating for a slower industrial base. The company competes against larger and well-funded rivals, and pricing pressure could cap margin gains. Its history of losses, divestitures, and restructuring shows how hard sustained profitability has been. As a low-priced small cap, the stock is volatile and can move sharply on single quarters or news, and convertible notes plus any future capital raises create dilution risk. It pays no meaningful dividend, so returns rely entirely on the turnaround working.

We give no verdict on 3D Systems Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Healthcare as the growth engine. The clearest bright spot is Healthcare Solutions, where Dental and Med Tech each grew over 20% year over year and the segment now rivals Industrial in size.

The case against. The central risk is that 3D Systems is a small, not-yet-consistently-profitable turnaround, so the thesis depends on execution that has not been fully proven.

Read the full bull and bear case on DDD, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see 3D Systems Corporation's investor relations page or your broker.

• Revenue (Q1 2026): ~$95.5 million, up ~1% reported (or ~11% excluding divestitures) year over year
• Segment mix: Healthcare ~$50 million (up ~21%) roughly matched Industrial ~$45 million
• Gross margin (Q1 2026, non-GAAP): ~36%, up from ~30% a year earlier on richer product mix
• Profitability: GAAP EPS loss narrowed to ~$(0.03); adjusted EBITDA slightly positive (~$2 million)
• Market cap: Small cap, roughly $0.5 billion; stock in the low single digits per share
• Balance sheet: Debt reduced sharply from 2021 levels; healthy current ratio; convertible notes outstanding

Figures are approximate and tied to the asOf date; verify live numbers before acting. Because 3D Systems is not consistently GAAP-profitable, traditional earnings multiples are not very meaningful, and the stock trades more on revenue growth, margin trajectory, and cash burn than on a stable P/E. As a low-priced small cap it can be volatile and sensitive to a single quarter. Treat this as a turnaround valuation, where the key is whether improving margins and healthcare growth translate into durable free cash flow.

These are the investment theses DDD naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to DDD: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get DDD exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so DDD sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where DDD fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

3D Systems is a small-cap additive-manufacturing turnaround: healthcare growth, better gross margins, and a slimmed-down cost base are narrowing losses, but it is not yet consistently profitable. It rewards patience if the pivot works and punishes it if demand or execution stalls.

Whether DDD is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is DDD a buy or a sell?, and where the stock could go from here in the DDD stock forecast.

For income investors, whether DDD pays a dividend and how the payout looks is covered in does DDD pay a dividend? And to weigh DDD against a peer, read the full side-by-side comparisons: DDD vs SSYS and DDD vs MTLS.